BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31400612)

  • 1. Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts.
    Shokoohmand A; Ren J; Baldwin J; Atack A; Shafiee A; Theodoropoulos C; Wille ML; Tran PA; Bray LJ; Smith D; Chetty N; Pollock PM; Hutmacher DW; Clements JA; Williams ED; Bock N
    Biomaterials; 2019 Nov; 220():119402. PubMed ID: 31400612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.
    Elshafae SM; Dirksen WP; Alasonyalilar-Demirer A; Breitbach J; Yuan S; Kantake N; Supsavhad W; Hassan BB; Attia Z; Alstadt LB; Rosol TJ
    Prostate; 2020 Jun; 80(9):698-714. PubMed ID: 32348616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment.
    Reichert JC; Quent VM; Burke LJ; Stansfield SH; Clements JA; Hutmacher DW
    Biomaterials; 2010 Nov; 31(31):7928-36. PubMed ID: 20688384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
    Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
    Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineered Microtissue Models of the Human Bone Metastatic Microenvironment: A Novel In Vitro Theranostics Platform for Cancer Research.
    Bock N
    Methods Mol Biol; 2019; 2054():23-57. PubMed ID: 31482446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The secreted matrix protein mindin increases prostate tumor progression and tumor-bone crosstalk via ERK 1/2 regulation.
    Ardura JA; Gutiérrez-Rojas I; Álvarez-Carrión L; Rodríguez-Ramos MR; Pozuelo JM; Alonso V
    Carcinogenesis; 2019 Jul; 40(7):828-839. PubMed ID: 31168562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.
    Raheem O; Kulidjian AA; Wu C; Jeong YB; Yamaguchi T; Smith KM; Goff D; Leu H; Morris SR; Cacalano NA; Masuda K; Jamieson CH; Kane CJ; Jamieson CA
    J Transl Med; 2011 Oct; 9():185. PubMed ID: 22035283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.
    Larson SR; Chin J; Zhang X; Brown LG; Coleman IM; Lakely B; Tenniswood M; Corey E; Nelson PS; Vessella RL; Morrissey C
    Clin Exp Metastasis; 2014 Feb; 31(2):247-56. PubMed ID: 24242705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
    Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.
    Lin SC; Lee YC; Yu G; Cheng CJ; Zhou X; Chu K; Murshed M; Le NT; Baseler L; Abe JI; Fujiwara K; deCrombrugghe B; Logothetis CJ; Gallick GE; Yu-Lee LY; Maity SN; Lin SH
    Dev Cell; 2017 Jun; 41(5):467-480.e3. PubMed ID: 28586644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
    Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
    Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer.
    Choudhary S; Ramasundaram P; Dziopa E; Mannion C; Kissin Y; Tricoli L; Albanese C; Lee W; Zilberberg J
    Sci Rep; 2018 Dec; 8(1):17975. PubMed ID: 30568232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer.
    Fradet A; Sorel H; Depalle B; Serre CM; Farlay D; Turtoi A; Bellahcene A; Follet H; Castronovo V; Clézardin P; Bonnelye E
    PLoS One; 2013; 8(9):e75092. PubMed ID: 24069383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
    Goya M; Ishii G; Miyamoto S; Hasebe T; Nagai K; Yonou H; Hatano T; Ogawa Y; Ochiai A
    Prostate; 2006 Nov; 66(15):1573-84. PubMed ID: 16927388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells.
    McGovern JA; Bock N; Shafiee A; Martine LC; Wagner F; Baldwin JG; Landgraf M; Lahr CA; Meinert C; Williams ED; Pollock PM; Denham J; Russell PJ; Risbridger GP; Clements JA; Loessner D; Holzapfel BM; Hutmacher DW
    Commun Biol; 2021 Aug; 4(1):1014. PubMed ID: 34462519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyurethane foam scaffold as in vitro model for breast cancer bone metastasis.
    Angeloni V; Contessi N; De Marco C; Bertoldi S; Tanzi MC; Daidone MG; Farè S
    Acta Biomater; 2017 Nov; 63():306-316. PubMed ID: 28927931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis.
    Sieh S; Taubenberger AV; Lehman ML; Clements JA; Nelson CC; Hutmacher DW
    Bone; 2014 Jun; 63():121-31. PubMed ID: 24530694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro bone metastasis dwelling in a 3D bioengineered niche.
    Han W; El Botty R; Montaudon E; Malaquin L; Deschaseaux F; Espagnolle N; Marangoni E; Cottu P; Zalcman G; Parrini MC; Assayag F; Sensebe L; Silberzan P; Vincent-Salomon A; Dutertre G; Roman-Roman S; Descroix S; Camonis J
    Biomaterials; 2021 Feb; 269():120624. PubMed ID: 33421710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.